UNSPSC 85251645: Diagnosis of malignant neoplasm on the overlapping lesion of digestive system

This classification denotes the group of activities that yields a diagnosis of Malignant neoplasm on the Overlapping lesion of digestive system. Malignant neoplasm on the Overlapping lesion of digestive system is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C26. 8

UNSPSC 85251645 Diagnosis of malignant neoplasm on the overlapping lesion of digestive system is a Commodity code that does not align with recent state and local procurement activity. The three most recent opportunities posted under this code—a diagnostic imaging PACS system procurement from San Mateo Medical Center, a special education contracted services RFP from Birdville Independent School District, and a temporary health professional staffing qualification vehicle from Santa Clara County Health System—fall outside the nominal scope of pathology diagnosis services for gastrointestinal cancers. The opportunities instead reflect health system infrastructure (PACS technology), educational services (school psychology, speech therapy, occupational therapy), and temporary clinical staffing (radiology, audiology, respiratory care, sterile processing). This mismatch suggests either a coding error in the state or local opportunity database or that the UNSPSC code is being used as a catch-all within health system procurement systems rather than as a precise commodity classifier. The code shows little relevant recent activity for malignant neoplasm diagnostic services as traditionally defined.

Geographic activity reflected in the recent-opportunities block spans California (San Mateo County, Santa Clara County) and Texas (Tarrant County). The issuing bodies are a public hospital system, a school district, and a county health system—representing mixed governance structures typical of mid-size municipal and regional health and education buyers. Without opportunities aligned to the code's stated scope, the geographic and issuing-body characterization cannot support a meaningful forward-looking assessment of demand for diagnostic pathology services under this taxonomy code.